Determinants in gammaretroviral Env dictate the production of neutralizing antibodies
Preprint
Abstract
Protective immune responses are shaped by the nature of the infectious pathogen. Some viral infections are self-limiting and stimulate lasting immunity, while others activate poor responses that fail to control the infection or prevent development of disease. Little is known concerning the specific viral determinants that control whether a given viral infection will result in protective immunity. Here, we demonstrate that strains of the gammaretrovirus, murine leukemia virus, differ in their ability to stimulate neutralizing antibody production via a noncanonical pathway. Additionally, we show that virus-specific production of neutralizing immune responses is unique to infection, suggesting that the activation of alternative antibody responses is triggered by the infectious process rather than the unique nature of specific viral antigens. Viral chimeras indicate that activation of neutralizing antiviral antibody production is determined by the receptor-binding domain, and that the surface subunit controls binding to and infection of various cell types. The ability of specific viral factors to determine the outcome of infection and the induction of distinctive immune responses between closely related retroviral strains provides an ideal model for the dissection of both host and viral determinants underlying the control of viral infection and the production of neutralizing antibodies. SUMMARY: We report here that retroviral envelope glycoprotein determines stimulation of GC B cell responses and the production of neutralizing antibodies in the absence of IFNγ-signaling, thus defining the factors that stimulate non-canonical immune responses and further developing the knowledge required for vaccine development.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R03AI180680)
- National Institute of Allergy and Infectious Diseases (T32 AI049820)
- National Institute of General Medical Sciences (R35GM154844)
- Children“s Hospital of Pittsburgh of the UPMC Health System
- Diane and Cliff Rowe Research Fund
This publication has 71 references indexed in Scilit:
- Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-ObImmunity, 2017
- Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteinsVirus Research, 2017
- Innate Immune Sensing of Retroviral Infection via Toll-like Receptor 7 Occurs upon Viral EntryImmunity, 2011
- Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2004
- Expression of receptor for ecotropic murine leukemia virus on hematopoietic cellsArchives of Virology, 2001
- Effects of Subtle Changes in the SU Protein of Ecotropic Murine Leukemia Virus on Its Brain Capillary Endothelial Cell Tropism and Interference PropertiesVirology, 1996
- Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCRAnnals of Hematology, 1994
- Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different formsAntiviral Research, 1987
- Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) miceCellular Immunology, 1974
- Plaque assay techniques for murine leukemia virusesVirology, 1970